Approaches to Rapid In Vivo Optimization of Hydrophilic Matrix Tablets

The optimisation of hydrophilic matrix tablets to balance formulation, biopharmaceutical, and physiological variables to achieve a target product profile is a complex process. Traditionally this optimisation process has relied upon application of a series of in vitro, preclinical, and clinical experimentation which extend programme timelines and increase cost to the development programme.